OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

To reveal more filter options, please select whether you would like to review Active or Closed projects:

Clear
Investigator: John Schetz

2 Projects | 1 Researchers | $415,803 Invested

2014

University of North Texas Health Science Center at Fort Worth

John Schetz, PhD

Target-based Discovery of Druggable Regulators of Peroxynitrite-Induced Nitration as a Novel Treatment Strategy for Alzheimer's Disease

  • Funding Amount: $216,000
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Target: Oxidative Stress
  • Status: Closed

2012

University of North Texas Health Science Center at Fort Worth

John Schetz, PhD

Target-based discovery of druggable regulators of peroxynitrite-induced nitration as a novel treatment strategy for Alzheimer's disease

  • Funding Amount: $199,803
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Target: Oxidative Stress
  • Status: Closed